Skip to main content

MIT Corporate Relations

MIT Corporate Relations
MIT Logo
  • Events
  • STEX25
  • Startups
  • opportunities
  • MIT ILP
  • Sign-In
  • Register Your Startup
  • Search
STEX Home
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
User Menu and Search
  • Sign-In
  • Register Your Startup
STEX Home
Toggle menu
  • Sign-in
  • Register your startup
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP

Search Results


Filter Results
Staff

Filter Results

Narrow your search results
  • News (4)
  • Videos (44)
  • Events (10)
  • Startup Opportunities (53)
  • Startups
  • Founders
Please sign-in to see the full search results
129 search results found
  • Lun Yu headshot

    10.5.23-Showcase-Tokyo-Metanovas_Biotech

    October 5, 2023 | Startup Exchange Video | Duration: 6:22
    AI+Knowledge Graph for Clinical-Grade Consumer Health Products
  • Past Deadline: May 8, 2020

    Nexa's Covid-19 Challenge 1. Hospital Safety

    other

    Nexa is seeking innovative solutions and technologies capable of preserving the health of health professionals, aiming to guarantee the availability of care for patients.  Winners to receive equity-free investment.

  • Past Deadline: Aug 3, 2023

    Call for Startups - BHP Challenge - Methane Emissions

    other

    BHP is seeking solutions that can measure, capture and convert fugitive methane emissions into a valuable or useful product. 

  • AI Driven Bloodless Blood Tests: GPx

    January 24, 2025 | Startup Exchange Video | Duration: 7:47

    AI Driven Bloodless Blood Tests
    Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx
    GPx: https://gpx.ai/

    In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.

    To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital 
    biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.

    Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.

    Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.

  • Past Deadline: Jul 1, 2021

    A Leading Global Bank seeks startups for Controls Automation

    partnership

    Global Bank looking to MIT to help drive its digital journey for Risk & Controls framework, both at pace and at scale, with automated end-to-end processes and underlying key controls, positioning the bank as an industry leader in this space.

  • Past Deadline: Mar 31, 2022

    Leading aviation company seeks startups in Extended Reality for partnerships

    partnership

    Jet Aviation AG seeks startups in Extended Reality for partnerships.

  • Straegen Bio - Greg Ekchian
    StratagenBio Logo b&w
    December 21, 2023 | Startup Feature

    Stratagen Bio: The Future of MRI

  • Arbor Biotechnologies

    Cambridge, MA
    Biotechnology
    Arbor Biotechnologies is an early stage life sciences company aiming to accelerate the discovery of proteins for improving human health and sustainability. The company was founded to harness recent advances in biology, computer science, and nanoscale engineering that together are unlocking unique... More
    Arbor_color
  • Past Deadline: Feb 28, 2023

    Speak at the 2023 MIT Health Science Technology Conference (April 4)

    speaker

    Looking for 10 Startups to present during Startup Lighting Talks and participate at the lunch Exhibit on April 4, 2023  at the 2023 MIT Health Science Technology Conference.

  • figur8, Inc.

    Boston, MA
    Consumer Products
    FIGUR8 has developed the first musculoskeletal diagnostics decision support system of its kind that can accurately pinpoint the source and severity of an injury while showing real-time recovery visibility. FIGUR8 began as a collaboration between MIT Media Lab researchers, Massachusetts General... More
    Keywords:
    MSK, musculoskeletal health, digital physical exam, digital health, Medical Device, MSK data, AI diagnostic, injury evaluation, injury recovery
    figur8 logo color

Pagination

  • of 9
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next page
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
  • Twitter
  • YouTube
  • LinkedIn
Home

1 Main Street
12th Floor, E90-1201
Cambridge, MA 02142


Accessibility

Privacy Policy

617-253-2691
startupexchange@mit.edu

Office of Corporate Relations